GATA5 is a transcription factor essential for cardiovascular development and cardiac homeostasis 1. It binds to specific DNA sequences in cardiac regulatory regions, including the troponin C transcriptional enhancer 2, and plays a critical role in smooth muscle cell differentiation and cardiac fibroblast reprogramming. Following myocardial infarction, GATA5/ISL1+ fibroblasts promote cardiac repair through Wnt signaling-mediated transformation of fibroblasts into functional cardiomyocytes; GATA5 overexpression ameliorates cardiac dysfunction and reduces fibrosis in mouse models 3. GATA5 functions as a tumor suppressor across multiple cancer types. Its expression is frequently lost through CpG island methylation in hepatocellular carcinoma and cholangiocarcinoma; restoration via demethylating agents suppresses tumor growth and metastasis via Wnt/β-catenin pathway inhibition 45. GATA5 variants associate with multiple cardiovascular conditions. Rare variants linked to blood pressure regulation show ~8-fold larger effects than common variants 6. Promoter variants increase ventricular septal defect susceptibility by altering GATA5 expression 7. Intronic GATA5 variants combined with HCN4 mutations increase atrial fibrillation risk 32.7-fold 8. Additionally, GATA5 methylation status predicts macrovascular events in type 2 diabetes with superior predictive accuracy versus clinical risk scores 9.